Absorption, distribution, metabolism drug solubility

Hansch and Leo [13] described the impact of Hpophihdty on pharmacodynamic events in detailed chapters on QSAR studies of proteins and enzymes, of antitumor drugs, of central nervous system agents as well as microbial and pesticide QSAR studies. Furthermore, many reviews document the prime importance of log P as descriptors of absorption, distribution, metabolism, excretion and toxicity (ADMET) properties [5-18]. Increased lipophilicity was shown to correlate with poorer aqueous solubility, increased plasma protein binding, increased storage in tissues, and more rapid metabolism and elimination. Lipophilicity is also a highly important descriptor of blood-brain barrier (BBB) permeability [19, 20]. Last, but not least, lipophilicity plays a dominant role in toxicity prediction [21]. 

This book is written for the practicing pharmaceutical scientist involved in absorption-distribution-metabolism-excretion (ADME) measurements who needs to communicate with medicinal chemists persuasively, so that newly synthesized molecules will be more drug-like. ADME is all about a day in the life of a drug molecule (absorption, distribution, metabolism, and excretion). Specifically, this book attempts to describe the state of the art in measurement of ionization constants (p Ka), oil-water partition coefficients (log PI log D), solubility, and permeability (artificial phospholipid membrane barriers). Permeability is covered in considerable detail, based on a newly developed methodology known as parallel artificial membrane permeability assay (PAMPA). 

Thus, %F is defined as the area under the curve normalized for administered dose. Blood drug concentration is affected by the dynamics of dissolution, solubility, absorption, metabolism, distribution, and elimination. In addition to %F, other pharmacokinetic parameters are derived from the drug concentration versus time plots. These include the terms to describe the compound s absorption, distribution, metabolism and excretion, but they are dependent to some degree on the route of administration of the drug. For instance, if the drug is administered by the intravenous route it will undergo rapid distribution into the tissues, including those tissues that are responsible for its elimination. 

The disadvantages of CD include (i) strict correlation between the structure of the guest molecule and the cavity size of the CD molecule (ii) limited solubility of CD in water, and thus limited the maximum concentrations this approach can achieve and (iii) CDs can signiLcantly modify absorption-distribution-metabolism-excretion/elimination (ADME) parameters if the binding constant K is too high, and thus limited the amount of free drug for absorption (Miller et al., 2006). 

The pharmacokinetic phase of drug action includes the Absorption, Distribution, Metabolism and Elimination (ADME) of the drug. Many of the factors that influence drug action apply to all aspects of the pharmacokinetic phase. Solubility (see Section 3.3), for example, is an important factor in the absorption, distribution and elimination of a drug. Furthermore, the rate of drug dissolution, that is, the rate at which a solid drug dissolves in the aqueous medium, controls its activity when a solid drug is administered by enteral routes (see Section 2.6) as a solid or suspension. 

The first section deals with physicochemical properties of compounds, which could influence their pharmacokinetic behavior tremendously. In particular, solubility and lipophilicity impact the penetration across membranes resulting in different pharmacokinetics. The next sections are focused on the four big pillars of pharmacokinetics absorption, distribution, metabolism and excretion. Each of those is subdivided into specialized topics explaining more specific and more detailed aspects. Since many patients take some drugs simultaneously, drug-drug interactions is an important topic to be considered both under a pharmacokinetic and a toxicological point of view. 

The pKa is an important physicochemical parameter. The analyte pKa values are especially important in regard to pharmacokinetics (ADME—absorption, distribution, metabolism, excretion) of xenobiotics since the pKa affects the apparent drug lipophilicity [59]. Potentiometric titrations and spectrophome-tric analysis can be used for pKa determination however, if the compound is not pure, is poorly soluble in water, and/or does not have a significant UV chromophore and is in limited quantity, its determination may prove to be challenging. 

The salt form is known to influence a number of physicochemical properties of the parent compound, such as dissolution rate, solubility, stability, and hygroscopicity. These properties, in turn, influence the absorption, distribution, metabolism, and excretion of the drug. This knowledge is essential for a complete understanding of the onset and duration of action, the relative toxicity, and the possible routes of administration. For example, certain salts of the strong base choline have proved to be considerably less toxic than their parent compound. This observation led to the... 

When one has to deal with a real new target, the only way to progress is to practice enough syntheses to identify the molecular features that are favorable and those that are detrimental to the activity. Such molecular variation programs can be practiced in several manners. Usually the predominant parameter wanted first is potency, but other qualities of the future drug molecules are relevant of drug optimization. One can mention selectivity, satisfactory ADME (absorption, distribution, metabolism, and excretion) and toxicity profiles, optimal physicochemical properties such as chemical stability, water solubility, and absence of polymorphs, finally the compounds must be patentable. Table 19.5, due to Baxter et al summarizes the different criteria practiced at the Astra-Zeneca company. 

The increase in new structures generated each year has not resulted in the expected increase of marketed new drugs annually. This has amongst others been attributed to poor pharmacokinetic (PK) properties of the CDs, and as much as 40% of the attrition rate of CDs has been related to poor PK profiles [1]. Given this, reliable screening filters for factors such as absorption, distribution, metabolism, elimination/excretion, and toxicity (ADMET) are highly desirable [2-4], Indeed, the considerable effort that has been invested in the development of experimental absorption filters, for example, cell monolayers for permeability determinations [5, 6] and the turbidimetric method for solubility measurements [7],... 

From an in vitro perspective, solubility in water and in organic solvents determines the choice of solvent, which, in turn, influences the choice of extraction procedure and analytical method. Solubility can also indirecfly impact the timeframe of an assay for compounds that are unstable in solution. From an in vivo perspective, the solubility of a compound influences its absorption, distribution, metabolism, and excretion. Both water solubility and lipid solubility are necessary for the absorption of orally administered antimicrobial drugs from the gastrointestinal tract. This is an important consideration when selecting a pharmaceutical salt during formulation development. Lipid solubility is necessary for passive diffusion of drugs in the distributive phase, whereas water solubility is critical for the excretion of antimicrobial drugs and/or their metabolites by the kidneys. 

---